Nagle C M, Bain C J, Green A C, Webb P M
Cancer and Population Studies Group, Queensland Institute of Medical Research, Brisbane, Australia.
Int J Gynecol Cancer. 2008 May-Jun;18(3):407-13. doi: 10.1111/j.1525-1438.2007.01031.x. Epub 2007 Jul 21.
Reproductive and hormonal exposures are known to influence ovarian carcinogenesis, but little is known about the effect of these factors on survival. We have studied survival according to hormonal and reproductive history in a population-based cohort of 676 Australian women aged 18-79, newly diagnosed with invasive epithelial ovarian cancer in the early 1990s. In order to place our findings in context, we have also undertaken a systematic review of the pertinent literature. Detailed information about each woman's reproductive and contraceptive history was obtained from pregnancy and contraceptive calendars at the time of diagnosis. Cox regression was used to obtain multivariate adjusted hazard ratios (HR) and 95% confidence intervals (CI). A total of 419 (62%) of the 676 women died during the follow-up (giving a 5-year survival proportion of 44%). Apart from better survival for women who had ever breastfed (multivariate HR 0.74, 95% CI 0.55-0.98), we found no association between survival from invasive ovarian cancer and a range of hormonal and gynecological factors including parity, use of oral contraceptives, and histories of tubal sterilization or hysterectomy. Systematic review of the literature generally supported the lack of influence of these factors on survival from ovarian cancer. We conclude that, except for a possible survival advantage among women with a history of breastfeeding, reproductive and hormonal exposures prior to diagnosis do not influence survival from invasive ovarian cancer, in contrast to their substantial effects on etiology of this disease.
已知生殖和激素暴露会影响卵巢癌的发生,但这些因素对生存率的影响却知之甚少。我们在一个以人群为基础的队列中,对676名年龄在18至79岁之间、于20世纪90年代初新诊断为浸润性上皮性卵巢癌的澳大利亚女性,根据其激素和生殖史研究了生存率。为了将我们的研究结果置于背景中,我们还对相关文献进行了系统综述。在诊断时,从妊娠和避孕日历中获取了每位女性详细的生殖和避孕史信息。使用Cox回归来获得多变量调整后的风险比(HR)和95%置信区间(CI)。在676名女性中,共有419名(62%)在随访期间死亡(5年生存率为44%)。除了曾经哺乳的女性生存率较高外(多变量HR为0.74,95%CI为0.55 - 0.98),我们发现浸润性卵巢癌的生存率与一系列激素和妇科因素之间没有关联,这些因素包括产次、口服避孕药的使用以及输卵管绝育或子宫切除术史。对文献的系统综述总体上支持这些因素对卵巢癌生存率缺乏影响。我们得出结论,除了有哺乳史的女性可能存在生存优势外,诊断前的生殖和激素暴露不会影响浸润性卵巢癌的生存率,这与它们对该疾病病因的显著影响形成对比。